Site icon European Science-Media Hub

12 Covid-19 vaccines to watch

Ampoules with Covid-19 vaccine on a laboratory bench to fight the coronavirus sars-cov-2 pandemic

A range of Covid-19 vaccines are being developed worldwide. Which ones are authorised and assessed in the EU? Which are still in development? Check our table below.

Company Type Efficacy* Doses Storage Status in Europe* Secured by EU

Pfizer / BioNTech πŸ‡©πŸ‡ͺπŸ‡ΊπŸ‡Έ

mRNA*

95%

πŸ’‰πŸ’‰
(πŸ’‰)

-25Β°C to -15Β°C

Authorised

2.4 bn
Moderna πŸ‡ΊπŸ‡Έ mRNA

94.1%

πŸ’‰πŸ’‰
(πŸ’‰)

-20Β°C

Authorised

460 mn
AstraZeneca / Oxford πŸ‡ΈπŸ‡ͺπŸ‡¬πŸ‡§ Adenovirus-vectored technology*

60% – 82%

πŸ’‰πŸ’‰ Fridge

Authorised

400 mn
Johnson&Johnson / Janssen πŸ‡§πŸ‡ͺπŸ‡ΊπŸ‡Έ Adenovirus-vectored technology

67%

πŸ’‰ Fridge

Authorised

400 mn
Novavax πŸ‡ΈπŸ‡ͺπŸ‡ΊπŸ‡Έ Protein

89.3%

πŸ’‰πŸ’‰ Fridge

Authorised

~200 mn
CVnCoV – CureVac AG πŸ‡©πŸ‡ͺ mRNA ❔ πŸ’‰πŸ’‰ Fridge

Rolling review stopped

405 mn
Sputnik V – Gamaleya Research Institute πŸ‡·πŸ‡Ί Adenovirus-vectored technology

91.6%

πŸ’‰πŸ’‰

-18Β°C

Rolling review
Emergency use in Hungary, BiH, Serbia, Montenegro

CoronaVac – Sinovac πŸ‡¨πŸ‡³ Inactivated virus

Lack of data

πŸ’‰πŸ’‰ Fridge

Rolling review
Emergency use in Turkey

BBIBP-CorV – Sinopharm πŸ‡¨πŸ‡³ Inactivated virus

Lack of data

πŸ’‰πŸ’‰ Fridge Emergency use in Hungary, Serbia
VLA2001 – Valneva πŸ‡«πŸ‡· Inactivated virus ❔ ❔ Fridge

In development

~60 mn

Sanofi & GSK πŸ‡«πŸ‡· (x2 vaccines)

mRNA & protein ❔ ❔ ❔

Rolling review of Vidprevtyn
(protein-based vaccine)

300 mn

β€’ Efficacy: numbers vary in different sources
β€’ mRNA: messenger RNA, part of the virus’ genetic code
β€’ Adenovirus-vectored technology: genetically modified cold virus
β€’ Status in Europe: overview of the situation in EU and in the candidates/potential candidates countries.
Sources: WHO, EMA, EC, Astrazeneca, Sanofi, JnJ, Novavax, SputnikVaccine, TheLancet, Nature & other.

Last update : 4 January 2022

Exit mobile version